Over the past several years, the dermatology industry has undergone a substantial amount of strategic repositioning and consolidation. Some of these activities have resulted in significant reductions in investment in research and development. At the same time there has been a slowdown in funding from governmental agencies, such as the NIH, that has dramatically reduced the percentage of competing research project grants funded. Despite these changes, at Advancing Innovation in Dermatology (AID), a not-for-profit organization committed to furthering innovation in our field, we are optimistic that there are sources and means for continuing to create and bring to market important and impactful new products for skin health. Furthermore, we believe that at a grassroots level, the dermatology community itself can play an important role in augmenting the usual avenues that provide the flow of technologies and treatments for patients.
Read full article: Download PDF
